Harald Hübner

8.0k total citations · 2 hit papers
202 papers, 6.2k citations indexed

About

Harald Hübner is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Harald Hübner has authored 202 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 159 papers in Molecular Biology, 97 papers in Cellular and Molecular Neuroscience and 50 papers in Organic Chemistry. Recurrent topics in Harald Hübner's work include Receptor Mechanisms and Signaling (125 papers), Neuropeptides and Animal Physiology (57 papers) and Chemical Synthesis and Analysis (54 papers). Harald Hübner is often cited by papers focused on Receptor Mechanisms and Signaling (125 papers), Neuropeptides and Animal Physiology (57 papers) and Chemical Synthesis and Analysis (54 papers). Harald Hübner collaborates with scholars based in Germany, United States and China. Harald Hübner's co-authors include Peter Gmeiner, Stefan Löber, Brian K. Kobilka, Olaf Prante, Jürgen Einsiedel, Aashish Manglik, Ralf C. Kling, Nuška Tschammer, Wolfgang Utz and Laura Bettinetti and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Harald Hübner

197 papers receiving 6.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Activation and allosteric modulation of a muscarinic acetylcholine receptor

2013 712 citations Andrew C. Kruse, Aashish Manglik et al. profile →
Structure-based discovery of opioid analgesics with reduced side effects

2016 697 citations Aashish Manglik, Daniela G. Dengler et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Harald Hübner Germany	38	4.5k	2.9k	1.4k	745	602	202	6.2k
Leonardo Pardo Spain	45	5.2k 1.2×	3.1k 1.1×	670 0.5×	565 0.8×	595 1.0×	157	6.8k
Peter Gmeiner Germany	48	7.7k 1.7×	4.5k 1.6×	2.9k 2.0×	1.2k 1.5×	954 1.6×	341	10.5k
Laura H. Heitman Netherlands	36	3.4k 0.8×	1.5k 0.5×	635 0.4×	507 0.7×	482 0.8×	152	4.5k
James C. Errey United Kingdom	33	3.3k 0.7×	1.2k 0.4×	977 0.7×	621 0.8×	389 0.6×	45	3.9k
J. Robert Lane United States	38	4.5k 1.0×	2.8k 1.0×	378 0.3×	608 0.8×	803 1.3×	101	5.8k
John D. McCorvy United States	30	3.0k 0.7×	2.5k 0.9×	790 0.5×	316 0.4×	508 0.8×	71	4.9k
Chris de Graaf Netherlands	46	5.0k 1.1×	1.8k 0.6×	657 0.5×	881 1.2×	1.8k 2.9×	139	6.7k
Marta Filizola United States	40	4.3k 1.0×	3.0k 1.1×	313 0.2×	569 0.8×	456 0.8×	140	5.7k
Moriz Mayer Austria	19	3.1k 0.7×	1.2k 0.4×	604 0.4×	371 0.5×	341 0.6×	42	4.3k
David E. Gloriam Denmark	38	6.9k 1.5×	3.7k 1.3×	422 0.3×	1.0k 1.4×	1.2k 2.0×	107	8.6k

Countries citing papers authored by Harald Hübner

Since Specialization

Citations

This map shows the geographic impact of Harald Hübner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harald Hübner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harald Hübner more than expected).

Fields of papers citing papers by Harald Hübner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harald Hübner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harald Hübner. The network helps show where Harald Hübner may publish in the future.

Co-authorship network of co-authors of Harald Hübner

This figure shows the co-authorship network connecting the top 25 collaborators of Harald Hübner. A scholar is included among the top collaborators of Harald Hübner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harald Hübner. Harald Hübner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Matzov, Donna, Liel Sapir, Harald Hübner, et al.. (2024). A bitter anti-inflammatory drug binds at two distinct sites of a human bitter taste GPCR. Nature Communications. 15(1). 9991–9991. 10 indexed citations

Hübner, Harald, et al.. (2023). Identification and quantification of kukoamine A and kukoamine B as novel μ-opioid receptor agonists in potato and other solanaceous plants. Food Chemistry. 427(8). 136637–136637. 2 indexed citations

Xu, Xinyu, Jeremy Shonberg, Jonas Kaindl, et al.. (2023). Constrained catecholamines gain β2AR selectivity through allosteric effects on pocket dynamics. Nature Communications. 14(1). 2138–2138. 13 indexed citations

Panel, Nicolas, Duc Duy Vo, Harald Hübner, et al.. (2023). Design of Drug Efficacy Guided by Free Energy Simulations of the β ₂ ‐Adrenoceptor. Angewandte Chemie International Edition. 62(22). e202218959–e202218959. 12 indexed citations

Khan, Shahbaz, Vladimir Ignatchenko, Harald Hübner, et al.. (2022). Phosphoproteomic Analysis of Dopamine D2 Receptor Signaling Reveals Interplay of G Protein- and β-Arrestin-Mediated Effects. Journal of Proteome Research. 22(1). 259–271. 2 indexed citations

Xu, Jun, Sheng Cao, Harald Hübner, et al.. (2022). Structural insights into ligand recognition, activation, and signaling of the α _2A adrenergic receptor. Science Advances. 8(9). eabj5347–eabj5347. 22 indexed citations

Hübner, Harald, et al.. (2022). Photochromic Fentanyl Derivatives for Controlled μ‐Opioid Receptor Activation. Chemistry - A European Journal. 28(63). e202201515–e202201515. 11 indexed citations

Hübner, Harald, et al.. (2021). Homobivalent Dopamine D₂ Receptor Ligands Modulate the Dynamic Equilibrium of D₂ Monomers and Homo- and Heterodimers. ACS Chemical Biology. 16(2). 371–379. 13 indexed citations

Buschauer, Armin, Hans‐Joachim Wittmann, Harald Hübner, et al.. (2021). Abolishing Dopamine D_2long/D₃ Receptor Affinity of Subtype-Selective Carbamoylguanidine-Type Histamine H₂ Receptor Agonists. Journal of Medicinal Chemistry. 64(12). 8684–8709. 9 indexed citations

10.

Kőszegi, Zsombor, Yann Lanoiselée, Harald Hübner, et al.. (2020). Investigation of Inactive-State κ Opioid Receptor Homodimerization via Single-Molecule Microscopy Using New Antagonistic Fluorescent Probes. Journal of Medicinal Chemistry. 63(7). 3596–3609. 16 indexed citations

11.

Hübner, Harald, et al.. (2020). Structure-based development of caged dopamine D2/D3 receptor antagonists. Scientific Reports. 10(1). 829–829. 16 indexed citations

12.

Maschauer, Simone, Olaf Prante, Peter Gmeiner, et al.. (2020). Synthesis, Radiosynthesis and Biological Evaluation of Buprenorphine‐Derived Phenylazocarboxamides as Novel μ‐Opioid Receptor Ligands. ChemMedChem. 15(13). 1175–1186. 5 indexed citations

13.

Scheiner, Matthias, Sandra Gunesch, Matthias Hoffmann, et al.. (2019). Dual-Acting Cholinesterase–Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in Vivo. Journal of Medicinal Chemistry. 62(20). 9078–9102. 39 indexed citations

14.

Wifling, David, et al.. (2019). Conjugation of Short Peptides to Dibenzodiazepinone-Type Muscarinic Acetylcholine Receptor Ligands Determines M₂R Selectivity. Journal of Medicinal Chemistry. 62(11). 5358–5369. 10 indexed citations

15.

Jaiteh, Mariama, Alexey A. Zeifman, Alena Randáková, et al.. (2017). Structure-Guided Screening for Functionally Selective D₂ Dopamine Receptor Ligands from a Virtual Chemical Library. ACS Chemical Biology. 12(10). 2652–2661. 33 indexed citations

16.

Dengler, Daniela G., et al.. (2017). Hydroxy-Substituted Heteroarylpiperazines: Novel Scaffolds for β-Arrestin-Biased D₂R Agonists. Journal of Medicinal Chemistry. 60(11). 4693–4713. 23 indexed citations

17.

Hübner, Harald, et al.. (2017). Photochromic Dopamine Receptor Ligands Based on Dithienylethenes and Fulgides. Chemistry - A European Journal. 23(54). 13423–13434. 41 indexed citations

18.

Weichert, Dietmar, Andrew C. Kruse, Aashish Manglik, et al.. (2014). Covalent agonists for studying G protein-coupled receptor activation. Proceedings of the National Academy of Sciences. 111(29). 10744–10748. 74 indexed citations

19.

Möller, Dorothée, et al.. (2014). Functionally Selective Dopamine D ₂ , D ₃ Receptor Partial Agonists. Journal of Medicinal Chemistry. 57(11). 4861–4875. 69 indexed citations

20.

Maschauer, Simone, Philipp Tripal, Roland Haubner, et al.. (2014). In Vivo Monitoring of the Antiangiogenic Effect of Neurotensin Receptor-Mediated Radiotherapy by Small-Animal Positron Emission Tomography: A Pilot Study. Pharmaceuticals. 7(4). 464–481. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact